共 35 条
- [21] KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreasMODERN PATHOLOGY, 2013, 26 (10) : 1346 - 1354Krasinskas, Alyssa M.Moser, A. JamesSaka, BurcuAdsay, N. VolkanChiosea, Simion I.
- [22] Day and night isotope labelling reveal metabolic pathway specific regulation of protein synthesis rates in ArabidopsisPLANT JOURNAL, 2022, 109 (04): : 745 - 763Duncan, OwenMillar, A. Harvey
- [23] CRISPR-Based Functional Genomics Studies Identify Mechanisms of Multiple Myeloma (MM) Cell Response to vs. Resistance Against Novel Pharmacological Mutant-Specific KRAS InhibitorsCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S180 - S181Steinbrunn, TorstenShirasaki, RyosukeDashevsky, OlgaTang, HuihuiYamano, ShizukaTeoh, Phaik JuLeypoldt, LisaMizuno, RinGlassner, BrianSimoes, Ricardo de MatosChristensen, JamesMitsiades, Constantine
- [24] Integrative proteomics, genomics, and translational immunology approaches reveal mutated forms of Proteolipid Protein 1 (PLP1) and mutant-specific immune response in multiple sclerosisPROTEOMICS, 2017, 17 (06)Qendro, VenetaBugos, Grace A.Lundgren, Debbie H.Glynn, JohnHan, May H.Han, David K.
- [25] Overcoming Cell Subtype-Specific Adaptive Resistance to KRAS G12D Inhibition in KRAS G12D-Mutant Pancreatic CancerCANCER RESEARCH, 2024, 84 (17)Lin, QingxiangMorales, AlvinBarnes, HaleyCorcoran, Ryan Bruce
- [26] Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancerCOMMUNICATIONS BIOLOGY, 2025, 8 (01)Zhang, NanWang, XinjiaLi, YuLu, YiweiSheng, ChengchengSun, YumengMa, NingyeJiao, Yisheng
- [27] Protein kinase B: emerging mechanisms of isoform-specific regulation of cellular signaling in cancerANTI-CANCER DRUGS, 2017, 28 (06) : 569 - 580Wadhwa, BhumikaMakhdoomi, UbaidVishwakarma, RamMalik, Fayaz
- [28] Deimination Protein Profiles in Alligator mississippiensis Reveal Plasma and Extracellular Vesicle-Specific Signatures Relating to Immunity, Metabolic Function, and Gene RegulationFRONTIERS IN IMMUNOLOGY, 2020, 11Criscitiello, Michael F.Kraev, IgorPetersen, Lene H.Lange, Sigrun
- [29] Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerONCOGENE, 2022, 41 (28) : 3640 - 3654Datta, JashodeepBianchi, AnnaSilva, Iago De CastroDeshpande, Nilesh U.Cao, Long LongMehra, SiddharthSingh, SamaraRafie, ChristineSun, XiaodianChen, XiDai, XiziColaprico, AntonioSharma, PrateekDosch, Austin R.Pillai, AshaHosein, Peter J.Nagathihalli, Nagaraj S.Komanduri, Krishna, VWilson, Julie M.Ban, YuguangMerchant, Nipun B.
- [30] Distinct mechanisms of innate and adaptive immune regulation underlie poor oncologic outcomes associated with KRAS-TP53 co-alteration in pancreatic cancerOncogene, 2022, 41 : 3640 - 3654Jashodeep DattaAnna BianchiIago De Castro SilvaNilesh U. DeshpandeLong Long CaoSiddharth MehraSamara SinghChristine RafieXiaodian SunXi ChenXizi DaiAntonio ColapricoPrateek SharmaAustin R. DoschAsha PillaiPeter J. HoseinNagaraj S. NagathihalliKrishna V. KomanduriJulie M. WilsonYuguang BanNipun B. Merchant